Using an immunofluorescence approach to label diverse tumor cells, Binder’s team reported for the first time in the 1990s the presence of Tau in the nuclei, especially near the nucleolar organizing regions of acrocentric chromosomes [76,77]. The gene discussed is MAPT; the disease is neoplasm.